/
•
•
The Byjus sold shares worth over $400 mn over 8 years
While the secondary sale of shares is not radical, it is important in this case because the Byju’s promoters have amassed massive wealth even as the company struggles
4 July, 2023•1 min
0
4 July, 2023•1 min
0
Getting your Trinity Audio player ready...
More in
Business
Cipla’s conservative approach is beginning to hurt
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
